These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 14555594

  • 1. Inhaled fluticasone propionate by diskus in the treatment of asthma: a comparison of the efficacy of the same nominal dose given either once or twice a day.
    Purucker ME, Rosebraugh CJ, Zhou F, Meyer RJ.
    Chest; 2003 Oct; 124(4):1584-93. PubMed ID: 14555594
    [Abstract] [Full Text] [Related]

  • 2. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma.
    ZuWallack R, Adelglass J, Clifford DP, Duke SP, Wire PD, Faris M, Harding SM.
    Chest; 2000 Aug; 118(2):303-12. PubMed ID: 10936117
    [Abstract] [Full Text] [Related]

  • 3. Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids.
    Chuchalin A, Jacques L, Frith L.
    Clin Drug Investig; 2008 Aug; 28(3):169-81. PubMed ID: 18266402
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [Abstract] [Full Text] [Related]

  • 5. Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids.
    Wolfe J, Rooklin A, Grady J, Munk ZM, Stevens A, Prillaman B, Duke S, Harding S.
    J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1153-61. PubMed ID: 10856150
    [Abstract] [Full Text] [Related]

  • 6. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A, Jarvis B.
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [Abstract] [Full Text] [Related]

  • 7. Comparison of once- with twice-daily dosing of fluticasone propionate in mild and moderate asthma.
    Boulet LP, Cowie RL, Negro RD, Brett W, Gold M, Marques A, Thorburn WS, Stepner NM, Robson R.
    Can Respir J; 2000 Nov; 7(3):239-47. PubMed ID: 10903487
    [Abstract] [Full Text] [Related]

  • 8. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM, Boulet LP, Follows RM.
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [Abstract] [Full Text] [Related]

  • 9. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.
    Jarvis B, Faulds D.
    Drugs; 1999 May; 57(5):769-803. PubMed ID: 10353302
    [Abstract] [Full Text] [Related]

  • 10. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
    Aalbers R, Backer V, Kava TT, Omenaas ER, Sandström T, Jorup C, Welte T.
    Curr Med Res Opin; 2004 May; 20(2):225-40. PubMed ID: 15006018
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma.
    LaForce CF, Pearlman DS, Ruff ME, Silvers WS, Weinstein SW, Clements DS, Brown A, Duke S, Harding SM, House KW.
    Ann Allergy Asthma Immunol; 2000 Nov; 85(5):407-15. PubMed ID: 11101186
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in patients with mild-to-moderate asthma.
    Falcoz C, Horton J, Mackie AE, Harding SM, Daley-Yates PT.
    Clin Pharmacokinet; 2000 Nov; 39 Suppl 1():31-7. PubMed ID: 11140431
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of fluticasone propionate 250 microg administered once daily in patients with persistent asthma treated with or without inhaled corticosteroids.
    Berger WE, Ford LB, Mahr T, Nathan RA, Crim C, Edwards L, Wightman DS, Lincourt WR, Rickard K.
    Ann Allergy Asthma Immunol; 2002 Oct; 89(4):393-9. PubMed ID: 12392384
    [Abstract] [Full Text] [Related]

  • 14. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H, Orozco S, Allen A.
    Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
    [Abstract] [Full Text] [Related]

  • 16. Steroid-sparing effects of fluticasone propionate 100 microg and salmeterol 50 microg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 microg administered twice daily.
    Busse W, Koenig SM, Oppenheimer J, Sahn SA, Yancey SW, Reilly D, Edwards LD, Dorinsky PM.
    J Allergy Clin Immunol; 2003 Jan; 111(1):57-65. PubMed ID: 12532097
    [Abstract] [Full Text] [Related]

  • 17. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
    Lee DK, Haggart K, Currie GP, Bates CE, Lipworth BJ.
    Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
    [Abstract] [Full Text] [Related]

  • 18. A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma.
    Nathan RA, Li JT, Finn A, Jones R, Payne JE, Wolford JP, Harding SM.
    Chest; 2000 Aug; 118(2):296-302. PubMed ID: 10936116
    [Abstract] [Full Text] [Related]

  • 19. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
    Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ.
    Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
    Kerwin EM, Nathan RA, Meltzer EO, Ortega HG, Yancey SW, Schoaf L, Dorinsky PM.
    Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.